Dexcom (DXCM) Enterprise Value (2010 - 2026)

Dexcom (DXCM) has reported Enterprise Value for 17 consecutive years, with $23.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value fell 25.03% year-over-year to $23.5 billion in Q2 2026; TTM through Jun 2026 was $23.5 billion, a 25.03% decrease from a year earlier, with the FY2025 full-year figure at $23.5 billion, down 15.34% from the prior year.
• Enterprise Value was $23.5 billion for Q2 2026 at Dexcom, up from $21.8 billion in the prior quarter.
• Over five years, Enterprise Value peaked at $52.0 billion in Q1 2024 and troughed at $21.8 billion in Q1 2026.
• A 5-year average of $33.5 billion and a median of $30.0 billion in 2022 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value surged 73.48% in 2023 and plunged 53.74% in 2025, its largest moves.
• Over 5 years, Enterprise Value stood at $41.3 billion in 2022, then rose by 9.23% to $45.1 billion in 2023, then plunged by 38.35% to $27.8 billion in 2024, then dropped by 15.34% to $23.5 billion in 2025, then slipped by 0.3% to $23.5 billion in 2026.
• The last three Enterprise Value figures came in at $23.5 billion (Q2 2026), $21.8 billion (Q1 2026), and $23.5 billion (Q4 2025), per Business Quant data.